Phase I IND-enabling studies for the amyloid-imaging peptide p5+14 (Api1832) - a novel agent for the detection of systemic amyloidosis

2018 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []